Population Surveys Scopes, Prevalence, Incidence, Health Registries - PowerPoint PPT Presentation

1 / 32
About This Presentation
Title:

Population Surveys Scopes, Prevalence, Incidence, Health Registries

Description:

Title: STROKE Epidemiologia Author: Ettore Beghi Last modified by: aaa Created Date: 3/6/2005 4:23:03 PM Document presentation format: Presentazione su schermo (4:3) – PowerPoint PPT presentation

Number of Views:76
Avg rating:3.0/5.0
Slides: 33
Provided by: Etto
Category:

less

Transcript and Presenter's Notes

Title: Population Surveys Scopes, Prevalence, Incidence, Health Registries


1
Population SurveysScopes, Prevalence, Incidence,
Health Registries
  • Ettore Beghi
  • Institute for Pharmacological Research Mario
    Negri, Milano, Italy

2
SCOPE OF POPULATION SURVEYS
  • Measure prevalence
  • Measure incidence
  • Measure mortality
  • Identify cases for case-control studies
  • Identify exposures for cohort studies
  • Study familial aggregation/genetics
  • Screen candidates for prevention/early treatment

3
ANATOMY OF A POPULATION SURVEY
  • Definition of the study population
  • Definition of disease
  • Case ascertainment (prevalence, incidence and
    mortality)
  • Calculation of epidemiological indexes
  • Distribution by time, place person

4
DIAGRAM OF THE IDENTIFICATION OF A DISEASE IN THE
GENERAL POPULATION
Kurtzke, 1978
5
HOW TO DEFINE A POPULATION
  • Geographic boundaries - Residency -
    Istituzionalization - Migration
  • Temporal boundaries - Prevalence period
    (point, period, lifetime) - Incidence period

6
MEASURES OF DISEASE FREQUENCY
  • INCIDENCE Number of individuals in a population
    that become ill in a stated period of time
  • CUMULATIVE INCIDENCE Proportion of a fixed
    population that becomes ill in a stated period of
    time
  • PREVALENCE Proportion of a population affected
    by a disease at a given point of time
  • MORTALITY Number of individuals in a population
    died for a disease in a stated period of time

7
PREVALENCE AND INCIDENCE
Prevalence Incidence x average duration
Incidence
Migrating in
Migrating out
Prevalence
Death
Recovery
8
SOURCES OF NEUROLOGICAL DISEASES IN
EPIDEMIOLOGICAL STUDIES
  • Hospital records
  • Ambulatory records
  • Electrophysiological (EMG) records
  • General practitioners files
  • Disability records
  • Lay associations
  • Tertiary centers
  • Death certificates
  • Diagnosis related groups (DRGs)
  • Disease registries

9
MIGRAINE IS A HETEROGENEOUS AND ILL-DEFINED
CLINICAL CONDITION
  • Intensity, duration, frequency and
    characteristics of attacks tend to vary in the
    general population
  • In each patient, symptoms may vary with time
  • Many individuals may have different types of
    headache
  • Many individuals do not consult their doctor for
    headache

10
MIGRAINE WITHOUT AURA (IHS, 1988)
  • A. At least 5 attacks with criteria B-D
  • B. Attacks lasting 4-72 hr (no or poor treatment)
  • C. Headache with at least two features -
    Unilateral - Pulsating - Moderate
    or severe
  • D. At least one among - Nausea and/or
    vomiting - Photophobia and/or phonophobia
  • E. At least one of the following - Other
    disturbances excluded by hx and examination -
    Other disturbances excluded by diagnostic
    tests - Other disturbances, but migraine attacks
    verified

11
CHANGE IN THE PREVALENCE OF MIGRAINE WHEN VARYING
THE NUMBER OF IHS DIAGNOSTIC CRITERIA
Merikangas et al, 1990
12
EPILEPSY AND EPILEPTIC SEIZURES
  • EPILEPSY Clinical condition characterized by
    repeated unprovoked seizures
  • UNPROVOKED SEIZURE Seizure occurring in the
    absence of known precipitants it may occur at
    the presence of a non-recent CNS injury
  • ACUTE SYMPTOMATIC SEIZURE Seizure occurring in
    close temporal relationship with an acute CNS
    insult

13
EPILEPSY, ACTIVE IN REMISSIONDefinitions
  • ACTIVE EPILEPSY epilepsy currently being treated
    or whose most recent seizure has occurred
    (usually) within the past two to five years
    (Thurman et al, Epilepsia, 2011)
  • EPILEPSY IN TERMINAL REMISSION absence of
    seizures for 2 or 5 years without AEDs

14
ACUTE SYMPTOMATIC SEIZURESInterval from
precipitating factor
CNS Insult Timing of occurrence
Stroke, head trauma, cerebral anoxia 1 week
Cerebral infection Positive clinical/laboratory findings
Brain abscess, cerebral tuberculoma During treatment
HIV infection Acute infection/metabolic disturb
Arterovenous malformation Acute hemorrhage
Multiple sclerosis Within 7 days of relapse
Autoimmune diseases Symptoms/signs of activation
Neurodegenerative disorders None identified
Epidemiology Task Force, Epilepsia 2009
15
EPIDEMIOLOGICAL INDEXES OF EPILEPSY IN
INDUSTRIALIZED COUNTRIES
  • Incidence Epilepsy 29-53 100,000/yr
    Epilepsysingle seizures 73-86 Acute sympt
    seizures 20-30 Status epilepticus 10-40
  • Cumulative incidence 1-3
  • Prevalence Active epilepsy 5-8
    x1,000 Lifetime 15-50
  • Mortality 1-4 x100,000/yr
  • SMR 2-3

16
DeCarli, Lancet Neurol 2003 215
17
PREVALENCE OF COGNITIVE IMPAIRMENT ACCORDING TO
CLINICAL DEFINITION
DeCarli, Lancet Neurol 2003 215
18
PROBLEMS REGARDING THE DIAGNOSIS OF POLYNEUROPATHY
  • The majority of the available data comes from
    clinical series
  • The diagnosis of polyneuropathy is based on
    clinical and elettrophysiological features
  • Polyneuropathy includes a wide spectrum of
    disorders ranging from symptomatic clinical
    conditions to subclinical variants
  • Diagnosis should be confirmed by a neurologist

19
Polyneuropathy in the ElderlyPrincipal Symptoms
  • Muscle cramps
  • Restless legs syndrome
  • Burning feet
  • Muscle pain
  • Problems with handling objects
  • Impairment of standing and gait
  • Glove and stocking paresthesiae

20
POLYNEUROPATHY IN THE ELDERLYValidity of the
screening questions
Monticelli et al, Neuroepidemiology 1993
21
POLYNEUROPATHY IN THE ELDERLYInter-rater
agreement (kappa statistic)
Monticelli et al, Neuroepidemiology 1993
22
EL ESCORIAL CRITERIA FOR THE DIAGNOSIS OF ALS
  • Based on the topographical location of upper
    (UMN) and lower motor neuron (LMN) signs in 4 CNS
    regions, progression of these signs, and absence
    of other diseases
  • Degree of diagnostic certainty (definite,
    probable, possible, suspected ALS) based on a
    different combination of UMN and LMN signs

Brooks, 1994
23
EL ESCORIAL CRITERIA FOR THE DIAGNOSIS OF ALS
  • DEFINITE ALS - LMN and UMN signs in 3
    spinal regions - LMN and UMN signs in the
    bulbar region and in 2 spinal regions
  • PROBABLE ALS - LMN and UMN signs in 2
    spinal regions
  • POSSIBLE ALS - LMN and UMN signs in 1
    region - UMN signs in 2 or more regions -
    LMN signs rostral to UMN signs
  • SUSPECTED ALS - LMN signs in 2 or more
    regions

Source J Neurol Sci 1994 124 (suppl) 96-107
24
DISEASE REGISTRIES
  • Lists of diseases (or disease groups) in
    well-defined populations
  • Collection of data on disease burden and
    identification of patients cohorts to be
    followed for specific purposes
  • For rare diseases, registries represent a
    (re)source for the collection of sizable numbers
    of cases for focused studies

25
EXPLANATIONS FOR HIGHER AND MORE HOMOGENEOUS
RATES IN EUROPEAN REGISTRIES
  • Prospective inception of cases
  • Multiple sources
  • Fairly complete case ascertainment
  • Continuous surveillance
  • Use of the same diagnostic criteria

26
OBJECTIVES OF A POPULATION-BASED REGISTRY
  • Incidence and prevalence of the target condition
  • Temporal and geographic trends of the disease
  • Full clinical spectrum of the disease
  • Clinical and paraclinical markers of the disease
  • Practical management and socio-economic
    implications of the disease
  • Data banks for clinical/biological material

27
PREREQUISITES FOR THE START OF A REGISTRY
  • Definition of the population at risk
  • Selection of the best source(s) of cases
  • Choice of the correct diagnostic criteria

28
SOURCES OF CASES
  • Hospital records
  • Outpatient records
  • Neurophysiology units archives
  • General practitioners files
  • Disability records
  • Lay associations files
  • ALS centers
  • Death certificates
  • Administrative files (hospital discharge
    diagnoses)

29
THE EURALS CONSORTIUM
  • Ireland 5.0M
  • Scotland 5.0M
  • Lancashire Cumbria 1.8M
  • London 2.8M
  • Italy (all) 8.0M
  • Belgrade 2.0M
  • Madrid 1.0M
  • Limousin 0.7M
  • Germany ?
  • Russia ?
  • Israel ?
  • Total gt25M

30
(No Transcript)
31
(No Transcript)
32
PRACTICAL RECOMMENDATIONS TO START A
POPULATION-BASED REGISTRY
  • Select a well-defined geographic area
  • Identify one or more accessible sources
  • Use valid and reliable diagnostic criteria
  • Set a network of specialists able to trace all
    cases residing in the area
  • Select a number of core variables to verify the
    correctness of the diagnosis and define the
    general profile of the disease
  • Start specific studies only after preparing
    ad-hoc protocols and case collection forms
Write a Comment
User Comments (0)
About PowerShow.com